Special Report: Increasing Racial Diversity in Clinical Trials
Clinical trials are the main way scientists develop new and improved cancer treatments. Yet less than 5 percent of adults with cancer participate in clinical trials, and most who do are white. Disparities in clinical trial participation among Black women could be one of the reasons they have worse breast cancer outcomes than other racial and ethnic groups in the United States.
For this Breastcancer.org Special Report, we spoke with experts and clinical trial participants about why diversity in clinical research matters, and how you can overcome common barriers that may be preventing you from participating in a breast cancer clinical trial.